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Abstract
Compared to healthy subjects, individuals with allergic airway disease (e.g., asthma, allergic 
rhinitis) have enhanced inflammatory responses to inhaled ozone. We created a rodent model of 
ozone-enhanced allergic nasal responses in Brown Norway rats to test the therapeutic effects of 
the dietary supplement g-tocopherol (γT). Ovalbumin (OVA)-sensitized rats were intranasally 
challenged with 0% or 0.5% OVA (in saline) on Days 1 and 2, and then exposed to 0 or 1 ppm 
ozone (eight hours/day) on Days 4 and 5. Rats were also given 0 or 100 mg/kg γT (p.o., in corn 
oil) on days 2 through 5, beginning twelve hours after the last OVA challenge. On Day 6, nasal 
tissues were collected for histological evaluation and mor-phometric analyses of intraepithelial 
mucosubstances (IM) and eosinophilic inflammation. Nasal septal tissue was microdissected and 
analyzed by reverse transcriptase polymerase chain reaction (RT-PCR) for mucin glycoprotein 
5AC (MUC5AC) expression levels. Histological analysis revealed mild to moderate eosinophil 
influx in the mucosa lining the nasal airways and maxillary sinus of OVA-challenged rats 
(eosinophilic rhinosinusitis). Ozone exposure of allergic rats further increased eosinophils in the 
maxillary sinus (400%), nasolacrimal duct (250%), and proximal midseptum (150%). Storage of 
intraepithelial mucosubstances (IM) was not significantly affected by OVA challenge in filtered 
air-exposed rats, but it was increased by ozone in the septum (45%) and maxillary sinus (55%) of 
allergic compared to control rats. Treatment with γT attenuated the ozone/ OVA-induced 
synergistic increases in IM and mucosal eosinophils in both nasal and paranasal airways. γ-
Tocopherol also blocked OVA and ozone-induced MUC5AC gene expression. Together, these 
data describe a unique model of ozone enhancement of allergic rhinosinusitis and the novel 
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therapeutic efficacy of a common supplement, γT, to inhibit ozone exacerbation of allergic airway 
responses.
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Introduction
Individuals with allergic airways disease are particularly sensitive to the adverse effects of 
ozone exposure. Increases in ambient ozone levels are associated with emergency room 
visits by asthmatic patients (Ko et al. 2007) and with increased use of asthma medication 
(Gent et al. 2003; Millstein et al. 2004). Nasal inflammation and adverse symptoms are 
reported in both healthy subjects (Kopp et al. 1999) and asthmatic patients with allergic 
rhinitis (Hiltermann et al. 1997) in response to episodic increases in ambient ozone 
concentrations.
Using a rodent model of allergic rhinitis, we have demonstrated that ozone exposure 
enhances allergen-induced mucous cell metaplasia (MCM) in both the transitional and 
respiratory epithelium of nasal airways (Wagner, Hotchkiss, and Harkema 2002). We have 
also described the temporal and spatial dependence of eosinophils with these epithelial 
alterations, although the mechanism by which ozone enhances allergic MCM and the role of 
eosinophils is not fully known. Acute exposure to ozone causes nasal epithelial and 
inflammatory responses in laboratory animals (Nikasinovic, Momas, and Seta 2003) and 
induces epithelial hyperplasia and MCM in the transitional and respiratory epithelium of 
both rats (Harkema et al. 1989) and monkeys. Neutrophil influx is required for the rapid 
induction of MCM by ozone, suggesting a critical role for acute inflammation in this process 
(Wagner, Hotchkiss, and Harkema 2001; Wagner et al. 2001).
Among the potential mechanisms contributing to airway pathobiology of allergic airway 
disease is an imbalance of oxidants and antioxidants. In allergic airway disease, antioxidants 
such as vitamins E (α-tocopherol; αT) and C (ascorbic acid) are decreased in airway lining 
fluids, whereas the oxidized form of glutathione is increased in this fluid compartment 
(Kelly et al. 1999; Kongerud et al. 2003; Ochs-Balcom et al. 2006). These decrements in 
airway antioxidant defenses could increase the sensitivity of allergic persons to acute ozone 
exposure. In a study in Mexico City, ozone-induced nasal lesions and oxidative DNA 
damage are more prevalent in children diagnosed with asthma (Calderon-Garciduenas et al. 
1999; Fortoul et al. 2003), and supplementation with α-tocopherol and ascorbate prevents 
ozone-induced nasal inflammatory responses in allergic children (Sienra-Monge et al. 2004). 
These studies support the hypothesis that therapeutic antioxidants likely limit the activity of 
environmental oxidants and prevent exacerbations of upper airway symptoms by ozone.
We have previously demonstrated that γ-tocopherol (γT), the major form of vitamin E in 
U.S. diets, has a number of anti-inflammatory actions, including blocking the production of 
tumor necrosis factor-α (TNFα), nitric oxide, and eicosanoid production during systemic 
nonallergic inflammatory challenge of laboratory rodents (Jiang and Ames 2003). Although 
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dietary guidelines for vitamin E are based on αT, several studies demonstrate that γT is 
more effective at trapping electro-philes such as reactive nitrogen species (Christen et al. 
1997; Cooney et al. 1993), inhibiting cycoloxygenase and inflammatory eicosanoid 
production (Jiang et al. 2000), and overall, providing a broader anti-inflammatory profile 
than αT (Jiang et al. 2001). With regard to allergic airways disease, many intervention 
studies with αT supplements have failed to protect from adverse airway responses in both 
humans and laboratory animals (Pearson et al. 2004; Shahar, Hassoun, and Pollack 2004; 
Suchankova et al. 2006), whereas dietary γT intake has been negatively associated with 
allergic sensitization (Kompauer et al. 2006). We have recently reported in detail that γT 
supplementation in allergic rodents can block ozone enhancement of allergic responses in 
the lung, specifically pulmonary inflammation and corresponding increases in airway mucus 
and cytokine production (Wagner et al. 2008).
In the present study, we extended our observations in this animal model of ozone 
exacerbation of allergic rhinosinusitis and tested the hypothesis that γT will inhibit 
pollutant- and allergen-induced epithelial and inflammatory responses in upper airways. Our 
results describe both the therapeutic effects of γT, as well as the unique interaction of ozone 
and allergen in paranasal airways that may be important for understanding human sensitivity 
to oxidant air pollutants.
Materials and Methods
Animals
Fifty-six male Brown Norway rats (Harlan, Indianapolis, IN), ten to twelve weeks of age, 
were randomly assigned to one of eight experimental groups (n = 7/group). Rats were free of 
pathogens and respiratory disease (based on health and pathology reports by the supplier) 
and were used in accordance with guidelines set forth by the All-University Committee on 
Animal Use and Care at Michigan State University. Animals were housed two per cage in 
polycarbonate boxes on aspen chip bedding, covered with filter lids, and they had free 
access to tap water and food (Tek Lad 22/5 Rodent Diet W 8649, Harlan Sprague Dawley, 
Indianapolis, IN, USA). During the inhalation portion of the study, rats were housed 
individually in rack-mounted stainless steel wire cages in Hazelton whole-body inhalation 
exposure chambers (HC-100, Lab Products, Maywood, NJ, USA). During ozone exposure, 
food was removed, but water was available.
γ-Tocopherol
d-gamma-tocopherol (γT; R,R,R naturally occurring, 96% pure by high performance liquid 
chromatography [HPLC] and nuclear magnetic resonance [NMR] analyses) was obtained 
from Yasoo Health, Inc. (Johnson City, TN, USA). Stock and diluted preparations were kept 
under nitrogen at 4 °C and contained no other tocopherols/tocotrienols or oxidation 
products, as confirmed by HPLC. Prior to treatment protocols, γT was diluted in tocopherol-
stripped corn oil (Dyets, Inc., Bethlehem, PA).
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Ozone was generated with an OREC model O3V1-O ozonizer (Ozone Research and 
Equipment Corp., Phoenix, AZ, USA) using compressed air as a source of oxygen. Total 
airflow through the exposure chambers was 250 L/minute (fifteen chamber air changes per 
hour). The concentration of ozone within the chambers was monitored throughout the 
exposure using two Dasibi 1003 AH ambient air ozone monitors (Dasibi Environmental 
Corp., Glendale, CA, USA). Sampling probes were placed in the breathing zone of rats 
within the middle of the cage racks. The concentration of ozone during exposures was 0.994 
+ 0.012 ppm (mean + standard error of the mean [SEM]) for ozone chambers and less than 
0.02 ppm for chambers receiving filtered air.
Treatment and Exposure Protocols
The time course for treatment protocols is summarized in Figure 1. On Day 1, rats were 
sensitized to chicken albumin (ovalbumin; OVA; Sigma Chemical Co., St. Louis, MO) by 
intraperitoneal injection with 2.5 mL sterile saline of a solution containing 1 mg OVA 
prepared with 10 mg alum (aluminum potassium sulfate), which acts as an adjuvant. Two 
weeks later, rats were challenged to OVA or saline for two consecutive days (i.e., Days 14 
and 15) under light anesthesia (4% halothane in oxygen) by intranasal instillation (IN) with 
150 mL of 0% or 0.5% OVA in sterile injectable saline into each nasal passage (300 mL 
total volume). Intranasal instillation (IN) challenge procedures were conducted between 
10:00 and 11:00 AM each day.
Beginning eight hours after the last IN challenge, rats were administered by oral gavage with 
0 or 100 mg/kg body weight γT prepared in tocopherol-stripped corn oil. Treatment with γT 
was repeated daily at 6:00 PM for four consecutive days (Days 15–18). Beginning on Day 
17, animals were exposed to 0 or 1.0 ppm ozone for eight hours per day (7:30 AM–3:30 
PM) for two consecutive days (Days 17 and 18). Animals were euthanized and tissues were 
collected on Day 19.
Necropsy, Lavage
Collection and Tissue Preparation—Rats were anesthetized with sodium pentobarbital 
(50 mg/kg, i.p. injection), and a midline laparotomy was performed. Four mL of blood was 
drawn into a vacutainer for separation of plasma, and animals were exsanguinated by cutting 
the abdominal aorta. After death, the head was removed and cleaned of skin and fur. Heads 
were split open to the reveal the right nasal cavity by cutting just off the midsagittal plane 
using the natural fissure separating nasal from maxillary and premaxillary bones of the 
proximal skull. The epithelium on the exposed right aspect of the proximal nasal septum was 
then microdissected (between T1 and T2 in Figure 2) and placed in RNALater solution 
(Qiagen, Valencia, CA) and stored at 4 °C until RNA was isolated. The left nasal cavity was 
then flushed retrograde with 1 mL of neutral-buffered formalin and then immersed in a large 
volume of the same fixative for storage. Twenty-four hours later, the heads were decalcified 
in 13% formic acid for five days. After decalcification, three nasal sections were taken from 
the anterior nasal cavity by making perpendicular cuts to the hard palate at the level (1) 
immediately posterior to the upper incisors, (2) at the incisive papilla, and (3) at the second 
palatine ridge (Figure 2). This procedure results in three anatomically specific nasal profiles 
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referred to here as T1, T2, and T3 and provides proximal to distal samples for morphometric 
and histological analysis. Tissue blocks were embedded in paraffin, and 5 to 6 mm thick 
sections were cut from the anterior surfaces. Nasal sections were stained with hematoxylin 
and eosin (H&E) for routine histology, with Alcian Blue (pH 2.5)/Peri-odic Acid-Schiff 
(AB/PAS) to detect intraepithelial mucosubstances (IM), or with May-Grunwald stain to 
detect mucosal eosinophils. Site-specific morphometry of IM and eosinophils was conducted 
for the epithelium and underlying mucosa lining the proximal nasal septum (T1), proximal 
and distal nasolacrimal duct (T2, T3), and the proximal and distal maxillary sinus(T2, T3) as 
depicted in Figure 2B.
Tocopherols—Plasma αT and γT were extracted using a mixture of methanol/hexane 
(2:5, v/v) in the presence of 0.8 mM butylated hydroxytoluene (BHT). After brief 
centrifugation at 4 °C, the top hexane layer was dried under N2 and the residue was 
resuspended in ethanol. Tocopherols were separated on a 150 × 4.6 mm, 5 mm Supelcosil 
LC-18-DB column (Supelco, Bellefonte, PA, USA) and eluted with 95:5 (v/v) methanol/ 
0.1M lithium acetate (final 25 mM, pH 4.75) at a flow rate of 1.3 mL/minute. Tocopherols 
were monitored by coulometric detection (Model Coulochem II, ESA, Inc., Chelmsford, 
MA, USA) at 300 (upstream) and 500 mV (downstream electrode) using a Model 5011 
analytical cell.
Morphometry of Stored Intraepithelial Mucosubstances (IM)—To estimate the 
amount of intraepithelial mucosubstances (IM) in nasal airways, the volume density (Vs) of 
AB/PAS-stained mucosubstances was quantified using computerized image analysis and 
morphometric techniques in the respiratory epithelium lining the midseptum and the 
maxillary sinus. Briefly, the area of AB/PAS-stained mucosubstance was estimated by 
setting colorized thresholds to highlight only IM, and these areas were then automatically 
calculated using the public domain NIH Image program (written by Wayne Rasband, U.S. 
National Institutes of Health and available on the Internet at http://rsb.info.nih.gov/nih-
image/). We define the midseptum for this purpose as the septal region that is between the 
tip of the nasoturbinate and the base of the maxilloturbinate (Harkema, Hotchkiss, and 
Henderson 1989). The entire perimeter of the maxillary sinus was evaluated. The length of 
the basal lamina underlying the surface epithelium was calculated from the contour length of 
the digitized image of the basal lamina. The volume of stored mucosubstances per unit of 
surface area of epithelial basal lamina was estimated using methods described previously 
(Harkema et al. 1987). The volume density (Vs) of intraepithelial mucosubstances is 
expressed as nanoliters of intraepithelial mucosub-stances per mm2 of basal lamina.
Morphometry of Tissue Eosinophil Numeric Density—The numeric density of 
eosinophils in the nasal mucosa lining the midseptum, maxillary sinus, and the proximal and 
distal aspects of the nasolacrimal ducts was determined by counting May-Grunwald-positive 
stained cells with distinct eosinophil morphology. The same sites were evaluated in the 
septum and sinus as described for IM, and the entire perimeter of the nasolacrimal duct was 
also evaluated. The length of the basal lamina was calculated from its contour length in a 
digitized image as described above, and the data are expressed as the number of eosi-nophils 
divided by the length of the underlying basal lamina.
Wagner et al. Page 5













Real Time RT-PCR—Mucin glycoprotein 5AC (MUC5AC) is the primary secretory 
mucin in airway epithelium, and we have previously demonstrated ozone and allergen-
induced expression of the MUC5AC gene that was associated with mucous cell metaplasia 
in the nasal septum (Wagner, Hotchkiss, and Harkema 2002). We therefore evaluated nasal 
expression of MUC5AC in the present study to determine if γT would modulate both stored 
epithelial mucus and gene expression for the mucin protein in the same tissue. Total RNA 
from septal epithelium was extracted using the RNeasy Mini Kit (Qiagen) according to the 
manufacturer’s instructions. The evaluation of relative expression levels of rat MUC5AC 
mRNA (Applied Biosystems, Foster City, CA USA) was performed by two-step RT-PCR 
using manufacturer protocols. Briefly, reverse transcription was performed using High 
Capacity cDNA Archive Kit (Applied Biosystems) reagents. Quantitative mRNA expression 
analysis was performed using an ABI PRISM 7900 HT Sequence Detection System at 
Michigan State University’s Research Technology Support Facility using Taqman Gene 
Expression Assay reagents (Applied Biosystems). Relative gene expression was normalized 
to 18S. Data are expressed as fold-increase in MUC5AC mRNA expression compared to 
control animals, which was set at a value of 1.
Statistical Analysis
Data are expressed as mean ± standard error of the mean (SEM). Data were analyzed using a 
completely randomized analysis of variance. Multiple comparisons were made by the 
Student-Newman-Keuls post hoc test. Criterion for significance was taken to be p < .05.
Results
Plasma Tocopherols
Plasma γT was unaffected by ozone exposure or allergen challenge regimens in control rats 
supplemented with 0 mg/ kg γT but was increased in all groups four- to five-fold with a dose 
of 100 mg/kgγT (Table 1). No differences were detected between exposure or challenge 
groups given γT. Plasma αT was similar in all groups given 0 mg/kgγT, with trends toward 
decreases in OVA-challenged rats. Allergic animals dosed with 100 mg/kgγT and exposed 
to filtered air had significantly less αT in plasma than saline-challenged, air-exposed rats.
Histopathology
Rats Intranasally Instilled with OVA and Exposed to Ozone—No exposure-related 
nasal lesions were present in control rats intranasally instilled with saline and exposed to 
filtered air. In contrast, OVA instillation induced a mild to moderate MCM or mucous cell 
hyperplasia/hypertrophy in the surface respiratory epithelium lining the proximal nasal 
airways (T1 and T2). This OVA-induced epithelial change, characterized by an increase in 
AB/PAS-stained mucous cells, was most conspicuous in the maxillary sinus (T2) and the 
proximal midseptum (T1) (Figure 3). These lesions were exacerbated by subsequent ozone 
exposure. Saline-instilled rats had a normal thin, ciliated, pseudostratified respiratory 
epithelium lining the maxillary sinus that contained no or only a few widely scattered ABA/ 
PAS-stained mucous goblet cells. In contrast, rats intranasally instilled with OVA had 
numerous AB/PAS-stained mucous cells (metaplastic change) that were increased in size 
and number after ozone exposure (Figure 3B). Although the ciliated respiratory epithelium 
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lining the proximal nasal septum in saline-instilled control rats contained tall columnar 
mucous cells with intracytoplasmic AB/PAS-stained mucosubstances, the number and size 
of these mucus-secreting cells were increased by OVA instillation, and further increased 
after ozone exposures (mucous cell hyperplasia/hypertrophy; Figure 3E).
A mild to moderate inflammatory cell influx composed mainly of eosinophils and lesser 
numbers of small lymphocytes and neutrophils was present in the mucosa lining the nasal 
airway and maxillary sinus of OVA-instilled and ozone-exposed rats (eosinophilic 
rhinosinusitis). Interestingly, minimal inflammatory cell infiltration was present in OVA-
instilled rats exposed only to filtered air. The eosinophilic influx in the OVA/ozone rats was 
most prominent in the subepithelial tissues (lamina propria) of the respiratory mucosa lining 
the proximal midseptum (T1, T2; Figure 4), the transitional mucosa lining the lateral wall 
(T1; Figure 5) and nasal turbi-nates (maxillo- and nasoturbinates; T1), the maxillary sinus 
(T3), and the nasolacrimal ducts (T1, T2; Figure 6).
Only rats exposed to ozone had minimal to mild epithelial hyperplasia of the transitional 
epithelium lining the proximal lateral meatus that was bordered in part by the lateral wall, 
maxilloturbinate, and lateral surface of the nasoturbinate in the T1 section. This hyperplastic 
epithelial change had a slightly greater severity in the OVA-instilled rats that were exposed 
to ozone.
Rats Intranasally Instilled with OVA, Exposed to Ozone, and Treated with γT—
In general, treatment with γT markedly attenuated the eosinophilic rhinosinusitis in OVA-
instilled and ozone-exposed rats. This treatment-related effect was most evident by the 
reduction of eosinophils in the mucosa lining the proximal midseptum (Figure 4), lateral 
wall (Figure 5), maxillary sinus, and nasolacrimal duct (Figure 6). In addition, there was a 
noticeable attenuation of mucous cell hyperplasia/hypertrophy of the respiratory epithelium 
lining the maxillary sinus (Figure 3C) and the proximal midseptum (Figure 3F) in these 
OVA-instilled rodents exposed to ozone.
Morphometry
Eosinophilic Numeric Cell Density—Exposure to ozone caused a twofold increase in 
eosinophils in the mucosa lining the nasal septum in nonallergic rats (Figure 7A), and 
similar increases were induced by OVA challenge. In allergic rats exposed to ozone, 
eosinophils increased 2.5-fold compared to animals exposed to ozone alone or challenged 
with OVA alone. Treatment with γT attenuated all exposure- and challenge-related increases 
in eosinophil accumulation in the septum.
In the maxillary sinus, ozone exposure or OVA challenge alone induced significant 
recruitment of eosinophils into the mucosa (1.5-fold increases compared to saline-
challenged, air-exposed control rats; Figure 7B). Eosinophil recruitment was synergistically 
enhanced by at least four-fold when allergic rats were exposed to ozone. Supplementation 
with γT completely blocked ozone-induced enhancement of sinus inflammation, but it had 
no effect on OVA-induced eosinophil accumulation.
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In both proximal and distal aspects of the nasolacrimal duct, ozone exposure or OVA 
challenge alone had no significant effect on eosinophil numbers in the ductal mucosa 
(Figures 7C and 7D). However, exposure of allergic rats to ozone caused eight-fold 
(proximal aspect) and five-fold (distal aspect) increases in the number of mucosal 
eosinophils. Treatment with γT completely blocked the synergistic eosinophil response to 
ozone and OVA in both regions of the nasolacrimal duct.
Mucous Cell Metaplasia—Ozone exposure had no effect on intraepithelial 
mucosubstances (IM) in the midseptum or maxillary sinus of nonallergic control rats (Figure 
8). Challenge with OVA in rats exposed to filtered air caused increased IM in the septum 
and proximal sinus that was significantly enhanced when allergic rats were exposed to ozone 
(Figures 8A and 8B). In distal aspects of the maxillary sinus, significant increases in IM 
were seen only in allergic rats exposed to ozone, which were 2.5- and five-fold greater 
compared to the OVA-only or ozone-only groups, respectively (Figure 8C). Treatment with 
γT attenuated IM increases in both the septum and sinus airways of ozone-exposed, allergic 
rats. However, the OVA-induced increases of IM in air-exposed rats were not affected by 
γT.
Mucin Gene Expression—Ozone exposure had no effect on MUC5AC expression in the 
nasal septum of nonallergic rats (Figure 9). Ovalbumin challenge induced a 2.5-fold increase 
in mucin gene expression compared to control animals. Exposure to ozone had no 
significant effect on OVA-induced gene expression compared to ozone exposure to 
nonallergic animals. In rats given γT, gene expression was attenuated in allergic rats, 
regardless of exposure.
Discussion
Clinical and epidemiological studies have demonstrated associations of ozone exposure with 
exacerbation of allergic responses in the upper airways (Kopp et al. 1999; Peden, Setzer, and 
Devlin 1995; Riediker et al. 2001). In the present study, we evaluated the effects of ozone 
exposure on nasal epithelial and inflammatory cell responses in an animal model of allergic 
rhinitis and sinusitis. Our results demonstrate for the first time in a rodent model (1) 
allergen-induced mucous cell metaplasia (MCM) in the maxillary sinus and (2) ozone 
enhancement of allergen-induced responses in both the maxillary sinus and the nasolacrimal 
duct. Inflammation in these two paranasal structures is associated with the morbidity of 
sinusitis and rhinoconjuctivitis. Furthermore these unique lesions were attenuated by γT, a 
vitamin E isoform with novel anti-inflammatory properties.
Using an allergen/ozone coexposure model, we have previously described ozone 
enhancement of allergic MCM in the respiratory epithelium of the nasal septum, among 
other site-specific lesions (Wagner, Hotchkiss, and Harkema 2002). In those studies, rats 
were challenged with allergen immediately after daily ozone exposures; thus, the nasal 
epithelium received these two inflammatory stimuli at more or less the same time. In the 
current protocol, we waited two days after intranasal allergen provocation before beginning 
ozone exposures; thus, exposure was to a nasal epithelium with pre-existing allergen-
induced alterations (airway remodeling). Similar to our results from the coexposure 
Wagner et al. Page 8













protocol, we found increased MCM in the nasal septum of allergic rats after ozone exposure 
(Figure 3). However, we also observed a robust influx of eosinophils into the nasal mucosa 
that was not seen in the previous coexposure study, suggesting that ozone-induced 
recruitment of inflammatory cells might contribute to the increased production and storage 
of intraepithelial mucosubstances. We have documented such a dependence with neutrophils 
and ozone-induced MCM in nonallergic models (Wagner et al. 2001). In the current study, 
blockade of both eosinophil and mucous responses in ozone-exposed rats by supplementing 
with γT suggests there may be a similar relationship for allergic MCM in nasal airways.
One of our most intriguing findings in the present study was the response to ozone and 
allergen in upper airways that was detected outside the main nasal cavity. Airway walls in 
the proximal and distal maxillary sinus had increased mucosub-stances and eosinophil influx 
in allergic rats (Figures 3, 7, and 8). We used rodent nasal diagrams (Mery et al. 1994) to 
identify the maxillary sinus duct that begins proximal to the ethmoid turbinbates and enters 
the skull where it opens into an enlarged paranasal sinus airway lined with respiratory 
epithelium that is totally enclosed within the bone. Similar to what we described in the 
septum, we detected a trend for ozone-induced enhancement of mucus and eosinophilic 
responses in proximal sinus airways. Furthermore, in distal aspects of the maxillary sinus at 
least 3 mm from the duct opening, we detected increased IM only in allergic rats exposed to 
ozone. That ozone can reach deep into low-flow regions of the paranasal sinus and induce 
mucous cell responses in allergic rats suggests that similar synergistic responses may occur 
in asymptomatic people with a history of allergic rhinitis and sinusitis. Previous work in our 
group demonstrated MCM in the maxillary sinus of F344 rats after twenty months of 
exposure to 0.5 or 1 ppm ozone (Harkema, Hotchkiss, and Griffith 1997). In those studies, 
the proximal sinus had IM increases five-fold greater and with more robust inflammation 
than what we observed in the present study with allergic rats exposed for two days to ozone. 
The airway epithelium lining the paranasal sinus normally has scant amounts of stored 
mucus, and the increases in response to acute ozone may precede even greater increases with 
chronic and intermittent allergen and ozone exposures.
We also found treatment-related changes in the nasolacrimal duct, which drains from the 
orbital socket and into the proximal nasal passages. In these sites, neither allergen nor ozone 
alone caused inflammation by itself, but the combination of the two created a robust influx 
of mucosal eosinophils greater than what was observed in the maxillary sinuses. Responses 
in proximal and distal regions of the duct were equally severe. It should be noted that the 
distal site that we evaluated is approximately 4 mm from the duct opening in the proximal 
nasal cavity and almost half the distance to the orbital socket. As such, it is tempting to 
speculate that ozone irritation of the ocular tissues might contribute to the downstream 
inflammation we found in the nasolacrimal duct. Increases in ambient ozone concentrations 
are associated with ocular irritation and enhancement of symptoms in allergic 
rhinoconjunctivitis patients (Riediker et al. 2001; Sanchez-Carrillo et al. 2003). Soluble 
inflammatory mediators such as IL-4 and TNFα are produced in conjunctiva of OVA-
induced allergic Brown Norway rats (Fukushima et al. 2003) and may drain into the 
nasolacrimal duct and mediate the recruitment of eosinophils into the mucosal tissues 
surrounding this duct. We have not yet examined more distal aspects of the duct closer to the 
eye or in ocular tissues to determine the extent of inflammation.
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We have recently reported that ozone enhancement of allergic responses also occurs in 
pulmonary airways (Wagner et al. 2007). Consistent with our current findings, we found that 
γT treatment attenuates pulmonary epithelial and inflammatory responses. In both the nose 
and the lung, γT inhibited ozone-specific enhancement, but not the allergen-induced MCM. 
In the current study, we saw this same relationship for both MCM and eosinophilic influx in 
the septum and proximal sinus. This may be a consequence of the timing of γT 
supplementation during allergic processes. Dosing with γT began ten hours after the second 
of two intranasal allergen challenges, at a time when significant eosinophilic infiltrates are 
present and increased intraepithelial mucosubstances induced by allergen are already evident 
(Wagner, Hotchkiss, and Harkema 2002). On the other hand, two treatments of γT had been 
given before the first ozone exposure, which is sufficient for plasma and lung content of γT 
to be significantly elevated (Wagner et al. 2008). Although nasal γT tissue levels were not 
determined in the current study to confirm an increase in bioavailability, this brief 
supplementation was apparently sufficient for γT content in nasal airways to protect from 
acute oxidant or inflammatory stimuli initiated by ozone inhalation.
Antioxidant supplements have been used successfully in humans suffering from 
micronutrient malnutrition to limit the severity of ozone-induced airway responses. For 
example, when people with deficits in dietary ascorbate were put on a supplementation 
regimen with αT, vitamin C, and vegetable juice, ozone-induced decrements in pulmonary 
function were less severe than in those receiving no supplementation (Samet et al. 2001). In 
asthmatic children with poor antioxidant nutrition, intervention with combinations of αT and 
vitamin C protected from nasal inflammatory responses during high ambient ozone episodes 
in Mexico City (Sienra-Monge et al. 2004). However, these studies are in contrast to a report 
by Mudway et al. (2006), in which acute ozone-induced lung function decrements and 
airway inflammation were unaffected in healthy, well-nourished subjects despite taking 
supplements with twice the concentrations of αT and vitamin C used in the two 
aforementioned studies. Taken together, these disparate outcomes suggest that interventions 
to protect from adverse ozone responses are useful only during antioxidant and 
micronutrient deficiency and that further supplementation provides no added benefits over 
adequate nutrition.
Results from animal studies also describe limitations in the efficacy of αT to protect from 
ozone- and allergen-induced airway responses. For example acute ozone exposure to 
BALB/c mice causes preferential increases in γT, ascorbate, and uric acid in 
bronchoalveolar lavage fluid compared to changes in αT (Jang et al. 2005). In addition, 
chronic ozone exposures and studies with dietary restriction suggest pulmonary antioxidant 
adaptation is dependent on mobilization and increases of pulmonary ascorbic acid, with no 
effect on αT (Kari et al. 1997; Wiester et al. 1996). In rodents with allergic airways, high αT 
doses of over 300 times the minimum suggested dietary intake for rodents fails to reduce 
allergen-induced pulmonary lesions or airway hyperreactivity (Suchankova et al. 2006). By 
comparison, we recently demonstrated the comprehensive protections by γT at similar doses 
against allergic responses in both upper and lower airways of rats (Wagner et al. 2008). We 
did not compare different vitamin E forms in our previous study; however, we have used a 
nonimmunogenic inflammation model to demonstrate that γT is superior to αT in limiting 
inflammatory cell recruitment and cytokine production (Jiang and Ames 2003). These 
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results in laboratory rodents suggest that the γ isoform of vitamin E may play a relatively 
more important role in pulmonary anti-inflammatory defenses and might help explain the 
lack of efficacy for αT supplements in controlled human studies.
Supplementation with γT might inhibit ozone-induced enhancement of allergic MCM via a 
number of antioxidant and anti-inflammatory pathways. Ozone is a strong oxidant with 
primary toxicity of epithelial cell injury and production of ozonated lipid mediators. Results 
from airway epithelial culture systems demonstrate a role for oxidative stress and reactive 
oxygen species in mucin gene expression and mucus production (Fischer and Voynow 2002; 
Shao and Nadel 2005). As such, γT might be limiting the direct oxidative effects of ozone 
on epithelial cells to initiate pathways that lead to mucus production. It is notable that the 
metaplastic response to ozone occurred only in the allergic rats, suggesting that this 
allergen-remodeled epithelium was somehow compromised or sensitized after OVA 
challenge to respond with enhanced signals to produce more mucus. These enhanced signal 
pathways were not present or effective when animals were supplemented by γT.
Alternatively, the metaplastic response might be engendered by products from infiltrating 
inflammatory cells that were called into the nasal mucosa after ozone exposure. Potential 
eosinophil-derived products that can stimulate mucin gene expression and protein 
production include nitric oxide (Adler et al. 1995; Song et al. 2007), cysteinyl leukotrienes 
(cysLTs) (Shimizu et al. 2000; Vargaftig and Singer 2003), and interleukin-13 (Vargaftig 
and Singer 2003). γ-tocopherol is a highly efficient quencher of nitric oxide and 
peroxynitrite in vitro (Wolf 1997), and we have previously demonstrated lipoxygenase 
inhibition by γT (Jiang and Ames 2003). Although γT can block the activity of these mucus-
stimulating factors, the recruitment and accumulation of eosinophils were attenuated by γT, 
thereby removing the putative sources of these inflammagenic mediators. It is not clear from 
the present results whether the inhibition of mucous cell responses by γT is due to direct 
effects on the epithelium, the inhibition of inflammatory cell recruitment, or both.
Ovalbumin-induced gene expression for the mucin glyco-protein MUC5AC was not 
enhanced after ozone exposure despite the increase in stored epithelial mucus in ozone-
exposed, allergic rats (Figures 8A and 9). Furthermore, while supplementing rats with γT 
suppressed gene expression, the increase in epithelial mucus was not affected in allergic rats. 
The apparent disconnect in intraepithelial mucus and gene expression may be explained by 
the analytic methods for each end point; histochemical staining with AB/PAS interacts with 
carbohydrate residues on the mucin glycoprotein surface, whereas RT-PCR reflects gene 
encoding the MUC5AC core protein. Further steps of translation and post-translation glyco-
sylation of the protein are required to produce the mucin glyoprotein identified by AP/PAS 
staining of intraepithelial mucosubstances. We have previously demonstrated the temporal 
delay between mucin gene expression and the appearance of intraepithelial mucus in the 
rodent nose (Cho, Hotchkiss, and Harkema 1999), which may further contribute to our 
disparate observations of ozone enhancement and γT-mediated attenuation in mucin gene 
and protein expression.
In summary, we describe for the first time an animal model of experimental allergic 
sinusitis, as well as the unique interaction between two disparate stimuli, an airborne 
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toxicant and an allergen, to produce inflammation and mucous cell metaplasia in nasal and 
paranasal airways. We have furthermore described the therapeutic effects of γT, an isoform 
of vitamin E with broad and novel anti-inflammatory properties that attenuate the effects of 
ozone in allergic upper airways. These findings in a rodent model warrant further 
investigation in clinical studies to determine the safety and efficacy of γT supplements 
against allergic rhinosinusitis and exacerbations by environmental triggers such as ozone.
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Experimental protocols. Rats were sensitized to OVA by intraperitoneal injection (ip) and 
two weeks later were challenged for two consecutive days by intranasal instillation (IN). 
Daily supplementation with γ-tocopherol (red box) started after the last challenge and 
continued to the duration of the study. Ozone exposures (black box) were conducted for two 
consecutive days prior to necropsy.
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Nasal sites of analysis. Three specific nasal profiles, T1, T2, and T3, were analyzed by 
morphometric and histological techniques. The nasal profile T1 is at the level immediately 
posterior to the upper incisors, T2 is at the incisive papilla, and T3 is at the second palatine 
ridge. Na = naris; N = nasoturbinate; MT = maxilloturbinate; 1–6E = ethmoids; NP = 
nasopharynx; L = lateral wall; DM = dorsal meatus; V = ventral wall; S = septum; HP = 
hard palate; NL = naso-lacrimal duct; MS = maxillary sinus.
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Intraepithelial mucosubstances in the maxillary sinus (A, B, C) and nasal septum (D, E, F). 
Animals were challenged with saline and exposed to filtered air (A, D), challenged with 
ovalbumin, exposed to ozone, and treated with 0 (B, E) or 100 mg/kg g-tocopherol (C, F). 
Tissues were stained with AB/PAS to detect intraepithelial mucosubstances (arrows). e = 
epithelium; g = gland; sc = septal cartilage.
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Mucosal eosinophils in nasal mid-septum. Animals were challenged with saline and exposed 
to filtered air (AD), challenged with ovalbumin, exposed to ozone, and treated with 0 (BE) 
or 100 mg/kg γ-tocopherol (CF). Tissues were stained with May-Grunwald (ABC) to detect 
eosinophils (arrows, pink-stained cells), or with hematoxylin and eosin (DEF). e = 
epithelium; g = gland; sc = septal cartilage.
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Mucosal eosinophils in nasal lateral wall. Animals were challenged with saline and exposed 
to filtered air (AD), challenged with ovalbumin, exposed to ozone, and treated with 0 (BE) 
or 100mg/kg γ-tocopherol (CF). Tissues were stained with May-Grunwald (ABC) to detect 
eosinophils (arrows, pink-stained cells), or with hematoxylin and eosin (DEF). e = 
epithelium; d = duct; g = gland; bv = blood vessel.
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Periductal eosinophils in the nasolacrimal duct. Animals were challenged with saline and 
exposed to filtered air (AD), challenged with ovalbumin, exposed to ozone, and treated with 
0 (BE) or 100 mg/kg γ-tocopherol (CF). Tissues were stained with May-Grunwald (ABC) to 
detect eosinophils (arrows, pink-stained cells), or with hematoxylin and eosin (DEF). e = 
epithelium; bv = blood vessel.
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Mucosal eosinophils in the midseptum (A), maxillary sinus (B), and the proximal and distal 
nasolacrimal ducts (C and D, respectively). Nasal sections were collected and stained with 
May-Grunwald, and site-selective morphometry of tissue eosinophils was conducted as 
described in the Methods section. n = 7; a = significantly different from respective group 
challenged with saline; b = significantly different from respective group exposed to filtered 
air; c = significantly different from respective group treated with 0 mg/kg γT (corn oil). p < .
05.
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Intraepithelial mucosubstances in the midseptum (A), and the proximal and distal maxillary 
sinuses (B and C, respectively). Nasal sections were collected and stained with AB/PAS, 
and site-selective morphometric evaluation of mucosubstances was conducted as described 
in the Methods section. n = 7; a = significantly different from respective group challenged 
with saline; b = significantly different from respective group exposed to filtered air; c = 
significantly different from respective group treated with 0 mg/kg γT (corn oil). p < .05.
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Mucin 5AC mRNA in the nasal septum. Mucosa was microdissected from the nasal septum, 
and RNA was isolated and processed by reverse transcriptase polymerase chain reaction, as 
described in the Methods section. n = 7; a = significantly different from respective group 
challenged with saline; c = significantly different from respective group treated with 0 
mg/kg γT (corn oil). p < .05.
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Table 1
Plasma tocopherol content in from rats exposed to air or ozone, challenged with saline or ovalbumin (OVA), 
with and without supplementation with γ-tocopherol.
Plasma tocopherols (µM)
Experimental groups γ-tocopherol α-tocopherol
Saline/air 0.35 ± 0.04 10.00 ± 1.27
Saline/ozone 0.41 ± 0.07 11.10 ± 1.25
OVA/air 0.27 ± 0.06 7.03 ± 1.55
OVA/ozone 0.35 ± 0.04 7.70 ± 1.26
Saline/air/γ-tocopherol 1.64 ± 0.23b 9.87 ± 0.41
Saline/ozone/γ-tocopherol 2.25 ± 0.39b 8.68 ± 1.10
OVA/air/γ-tocopherol 2.25 ± 0.24b 6.00 ± 1.36a
OVA/ozone/γ-tocopherol 2.02 ± 0.54b 8.70 ± 0.58
Note: Data are expressed as mean ± standard error of the mean.
a
Significantly different from respective group challenged with OVA.
b
Significantly different from respective group without γ-tocopherol supplementation.
p < 05.
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